HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Y-mAbs
SAN FRANCISCO, March 11, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)
Globe Newswire12-03-2023, 04:01
Akwel: Nine-Month Revenue Down -5.2% 7-11-2024, 23:45